117 related articles for article (PubMed ID: 21615056)
1. Metformin: an effective attenuator of risperidone-induced insulin resistance hyperglycemia and dyslipidemia in rats.
Adeneye AA; Agbaje EO; Olagunju JA
Indian J Exp Biol; 2011 May; 49(5):332-8. PubMed ID: 21615056
[TBL] [Abstract][Full Text] [Related]
2. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
3. Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.
Murashita M; Inoue T; Kusumi I; Nakagawa S; Itoh K; Tanaka T; Izumi T; Hosoda H; Kangawa K; Koyama T
Psychiatry Clin Neurosci; 2007 Feb; 61(1):54-8. PubMed ID: 17239039
[TBL] [Abstract][Full Text] [Related]
4. Anti-diabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats.
Zhang XF; Tan BK
Acta Pharmacol Sin; 2000 Dec; 21(12):1157-64. PubMed ID: 11603293
[TBL] [Abstract][Full Text] [Related]
5. Metformin improves immunosuppressant induced hyperglycemia and exocrine apoptosis in rats.
Shivaswamy V; Bennett RG; Clure CC; Larsen JL; Hamel FG
Transplantation; 2013 Jan; 95(2):280-4. PubMed ID: 23250335
[TBL] [Abstract][Full Text] [Related]
6. Lupin seed γ-conglutin lowers blood glucose in hyperglycaemic rats and increases glucose consumption of HepG2 cells.
Lovati MR; Manzoni C; Castiglioni S; Parolari A; Magni C; Duranti M
Br J Nutr; 2012 Jan; 107(1):67-73. PubMed ID: 21733318
[TBL] [Abstract][Full Text] [Related]
7. Increase of insulin sensitivity in diabetic rats received die-huang-wan, a herbal mixture used in Chinese traditional medicine.
Wu YC; Hsu JH; Liu IM; Liou SS; Su HC; Cheng JT
Acta Pharmacol Sin; 2002 Dec; 23(12):1181-7. PubMed ID: 12466058
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
9. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
[TBL] [Abstract][Full Text] [Related]
10. The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats.
Choi SH; Zhao ZS; Lee YJ; Kim SK; Kim DJ; Ahn CW; Lim SK; Lee HC; Cha BS
Diabetes Metab Res Rev; 2007 Jul; 23(5):411-8. PubMed ID: 17538941
[TBL] [Abstract][Full Text] [Related]
11. Effect of Sanguis draxonis (a Chinese traditional herb) on the formation of insulin resistance in rats.
Hou Z; Zhang Z; Wu H
Diabetes Res Clin Pract; 2005 Apr; 68(1):3-11. PubMed ID: 15811560
[TBL] [Abstract][Full Text] [Related]
12. Effects of digitonin on hyperglycaemia and dyslipidemia induced by high-sucrose intake.
Ebaid GM; Faine LA; Diniz YS; Rodrigues HG; Galhardi CM; Ribas BO; Fernandes AA; Novelli EL
Food Chem Toxicol; 2006 Feb; 44(2):293-9. PubMed ID: 16112785
[TBL] [Abstract][Full Text] [Related]
13. The antidiabetic effects of cysteinyl metformin, a newly synthesized agent, in alloxan- and streptozocin-induced diabetic rats.
Liu Z; Li J; Zeng Z; Liu M; Wang M
Chem Biol Interact; 2008 May; 173(1):68-75. PubMed ID: 18377884
[TBL] [Abstract][Full Text] [Related]
14. Metformin restores responses to insulin but not to growth hormone in Sprague-Dawley rats.
Borst SE; Snellen HG; Ross H; Scarpace PJ; Kim YW
Biochem Biophys Res Commun; 2002 Mar; 291(3):722-6. PubMed ID: 11855850
[TBL] [Abstract][Full Text] [Related]
15. D-psicose, a sweet monosaccharide, ameliorate hyperglycemia, and dyslipidemia in C57BL/6J db/db mice.
Baek SH; Park SJ; Lee HG
J Food Sci; 2010 Mar; 75(2):H49-53. PubMed ID: 20492234
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents.
Arman S; Sadramely MR; Nadi M; Koleini N
Saudi Med J; 2008 Aug; 29(8):1130-4. PubMed ID: 18690305
[TBL] [Abstract][Full Text] [Related]
17. Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia.
Smith AC; Mullen KL; Junkin KA; Nickerson J; Chabowski A; Bonen A; Dyck DJ
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E172-81. PubMed ID: 17374701
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of insulin action and tumor necrosis factor alpha system activity by metformin.
Biarnés J; Fernández-Real JM; Fernández-Castañer M; del Mar García M; Soler J; Ricart W
Metabolism; 2005 Feb; 54(2):235-9. PubMed ID: 15690319
[TBL] [Abstract][Full Text] [Related]
19. Effect of chronic co-administration of metformin and vitamin C on plasma glucose and lipid concentrations in normal rats.
Adeneye AA; Amole OO; Agbaje EO; Izegbu MC; Elias SO
Afr J Med Med Sci; 2007 Jun; 36(2):149-54. PubMed ID: 19205578
[TBL] [Abstract][Full Text] [Related]
20. Effect of N-benzoyl-D-phenylalanine on streptozotocin-induced changes in the lipid and lipoprotein profile in rats.
Ashokkumar N; Pari L; Manimekalai A; Selvaraju K
J Pharm Pharmacol; 2005 Mar; 57(3):359-66. PubMed ID: 15807992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
